• Anaphylaxis
• Drug Allergy
• Immunodeficiency
• Systemic Lupus Erythematosus

Professor Philip Li was the first locally trained Specialist in Immunology & Allergy in Hong Kong and currently serves as a Clinical Associate Professor at the University of Hong Kong (HKU). He is also Division Chief of Rheumatology & Clinical Immunology at both HKU and HKU-Shenzhen Hospital. Additionally, he is the President of the Hong Kong Institute of Allergy, Board Director of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) and Chair of the International Societies Committee of the European Academy of Allergy and Clinical Immunology (EAACI).

Prof Li has special interests in drug allergy, immunodeficiency and urticaria/angioedema. Notably, he established Hong Kong’s first specialist Immunology & Allergy training centre and leads the territory-wide Drug Allergy Delabelling Initiative (HK-DADI). As head of the Immunology & Allergy services of the Hong Kong West Cluster/HKU, he has steered the institution towards accreditation as both an Urticaria and Angioedema Centre of Reference & Excellence, as well as an EAACI Certified Clinic & Research Centre in Drug Allergy, World Allergy Organization and APAAACI Centre of Excellence. He is also the Chairperson of the APAAACI Drug Allergy Committee.

His research has earned notable recognition, including the Patrick Manson Gold Medal for Best MD Thesis and the Richard Yu Lectureship from the Hong Kong College of Physicians. In recognition of his advocacy work, he was honoured with the Humanitarian Award from the Hong Kong Red Cross. His substantial clinical contributions have been acknowledged with the Hong Kong Ten Outstanding Young Persons Award, Chief Executive’s Commendation for Public Service, and HKUMed Clinical Service Excellence Award. Additionally, he received the U21 Health Sciences Group Teaching Excellence Award and HKUMed Knowledge Exchange Award, and was named one of 23 “Young Physician Leaders” in 2026.

Prof Li's influence is clearly demonstrated through his significant contributions to various local and international guidelines. These include guidelines on chronic urticaria, hereditary angioedema, and his role as the lead author of the clinical pathway for penicillin allergy testing in the Asia Pacific region. He has authored over 200 peer-reviewed articles in allergy, immunology, and autoimmunity, including publications in leading journals such as the Lancet, NEJM, Nature Medicine, Nature Genetics, Allergy, and JACI.

1. Oral deucrictibant for on-demand treatment of hereditary angioedema attacks: a phase 3, multicentre, randomised, double-blind, placebo-controlled crossover trial
   Riedl MA*, Li PH (Co-first author)*, Adatia A, Cancian M, Stobiecki M, Valerieva A, Grumach AS, Lumry WR, Soteres DF, Brodszki N, Fili NL, Hakl R, Kang HR, Karakaya G, Kränke B, Li HH, Peter J, Recke A, Tachdjian R, Triggianese P, Zanichelli A, Anderson J, Aygören-Pürsün E, Craig TJ, Farkas H, Giardino F, Giavina-Bianchi P, Kim S, Kinaciyan T, Martinez-Saguer I, Perego F, Sitz KV, Staevska M, Wedner HJ, Zaragoza-Urdaz RH, Zwiener RD, Gelincik A, Arcoleo F, Arnaout R, Baptist AP, Campos RDA, Dorr AD, Ferriani MPL, Fukunaga A, Gobert D, Gurugama P, Hide M, Hong DI, Inage E, Jacobs JS, Katelaris CH, Leeman L, Lleonart R, Magerl M, Manning ME, Mano S, Ooka S, Ramos CJ, Liu J, Zhu L, Mendivil J, Katbeh U, Giannattasio G, Crabbé R, Yu M, Lesage A, Lu P, Cohn DM.
   Lancet. 2026 Oct 8:S0140-6736(26)01296-1. doi: 10.1016/S0140-6736(26)01296-1.
    
2. Prospective Registry of Outcomes, Treatment, and Clinical Trajectories for Anti-IFN-γ Immunodeficiency
   Chiang V, Chung KLF, Leung NY, Ip WK, Chu GKH, Hooi JKY, Wong CYJ, Au YLE, Li PH (Corresponding author).
   JAMA Netw Open. 2026 Jul 1;9(7):e2623220. doi: 10.1001/jamanetworkopen.2026.23220.
    
3. Modeling Hereditary Angioedema With Personalized EPSC-Derived Hepatocytes: A CRISPR-Validated Platform for Mutation-Specific Mechanisms and Therapeutic Innovation
   Liu X, Wang Y, Wong JCY, Zhang X, Wu C, Chen P, Yang Y, Liu P, Lau CS, Cook M, Li PH (Corresponding author).
   Allergy. 2026 Aug;81(8):2858-2873. doi: 10.1111/all.70419.
    
4. Global Real-World Validation of First-Day Urticaria Activity Score (UAS1)
   Su LH, Sousa Pinto B, Ramanauskaite A, Witte-Händel E, Arnau AG, Cherrez-Ojeda I, Kocatürk E, Weller K, Bousquet J, Magerl M, Zuberbier T, Metz M, Neisinger S, Li PH (Corresponding author).
   J Allergy Clin Immunol Pract. 2026 Apr 20:S2213-2198(26)00333-8. doi: 10.1016/j.jaip.2026.04.011.
    
5. Prospective Multi-Regional Evaluation of Protocol-Based Penicillin Allergy Delabelling in China: Real-World Outcomes Challenge Mandatory Pre-emptive Skin Testing Policies
   Li PH (Corresponding author), Xu F, Shi W, Chik TSH, Chu MY, Li TCM, Huang JX, Kan AKC, Liu N, Zhang X, Meng J. 
   J Allergy Clin Immunol Pract. 2025 Dec 12:S2213-2198(25)01160-2. doi: 10.1016/j.jaip.2025.12.004. 
    
6. Impact of a drug allergy education course for non-specialists: findings from ADAPT – a randomized crossover trial
   Lucas M, Mak HWF, Lee JTY, Kulkarni R, Chan SSC, Li PH (Corresponding author).
   Allergy. 2024 Aug 7. doi: 10.1111/all.16270. 
    
7. Recapitulating primary immunodeficiencies with expanded potential stem cells: Proof of concept with STAT1 gain of function
   Li X, Chan VSF, Smith KGC, Ming C, Or CS, Tsui FTW, Gao B, Cook MC, Liu P, Lau CS, Li PH (Corresponding author).
   J Allergy Clin Immunol. 2024 Apr;153(4):1125-1139. doi: 10.1016/j.jaci.2023.11.914.
    
8. Prospective, multi-centre, head-to-head comparison between allergists vs non-allergists in low-risk penicillin allergy delabelling: effectiveness, safety and quality of life (HK-DADI2)
   Wong JCY, Kan AKC, Chik TSH, Chu MY, Li TCM, Mak HWF, Chiang V, Li PH (Corresponding author).
   J Allergy Clin Immunol Pract. 2024 Apr 16:S2213-2198(24)00394-5. doi: 10.1016/j.jaip.2024.04.010. 
    
9. Prospective study on the efficacy and impact of Cascade Screening and Evaluation of HAE (CaSE-HAE)
   Wong JCY, Chiang V, Lam K, Tung E, Au EYL, Lau CS, Li PH (Corresponding author).
   J Allergy Clin Immunol Pract. 2022 Aug 11 doi: 10.1016/j.jaip.2022.07.035.
    
10. Prevalence, Incidence, and Sensitization Profile of β-lactam Antibiotic Allergy in Hong Kong
    Li PH (Corresponding author), Yeung HHF, Lau CS, Au EYL.
    JAMA Netw Open. 2020 May 1;3(5):e204199. doi: 10.1001/jamanetworkopen.2020.4199. 

1. Living with allergies -  “與過敏症自在同行”
   Li PH, Ho MHK, Lam E.

1. Mapping the Endotypes of Antibiotic Reactions
   Li PH, Barbaud A, Lucas M.
   Antibiotic Allergy: Phenoendotypes in Drug Hypersensitivity Mechanisms
2. Available biomarkers in clinical practice of allergy
   Li PH, Mak H.
   Biomarkers in Allergy. 
3. Management of antibiotic allergy
   Li PH.
   Interhospital Multi-disciplinary Programme on Antimicrobial Chemotherapy (IMPACT) 6th Edition, 2024
4. Immunology & Allergy; Handbook of Internal Medicine
   Li PH.
   Hospital Authority Handbook of Internal Medicine 9th Edition, 2024
5. Immunology & Allergy; Handbook of Internal Medicine
   Li PH.
   Hospital Authority Handbook of Internal Medicine 8th Edition, 2019

1. Nomenclature on Immune-Mediated Drug Reactions: An EAACI Position Paper 
   Torres MJ, Mayorga C, Phillips EJ, Ariza A, Barbaud A, Bonadonna P, Castells M, Çelik G, Brockow K, Garvey LH, Doña I, Caubet JC, Mori F, Trubiano J, Marta G, Romano A, Terreehorst I, Gelincik A, Li PH, Sabato V.
   Allergy 2026 Aug 17. doi: 10.1111/all.70419.
    
2. World Allergy Organization Sublingual Immunotherapy Position Paper: 2026 update: Global expert consensus on efficacy, safety, disease modification, and implementation
   Canonica GW, Morais-Almeida M, Di Bona D, Ansotegui IJ, Oppenheimer JJ, Al-Nesf M, Bernstein JA, Caimmi D, Chang YS, Davis CM, Ebisawa M, Fiocchi A, Gómez RM, González-Díaz SN, Hong SJ, Papadopoulos NG, Pawankar R, Peter JG, Rojo Gutiérrez MI, Tantilipikorn P, Virchow JC, Wong GWK, Zachary CY, Fernandez-Caldas E, Durham SR, Alangari AA, Ishchanka A, Abdul Latiff AH, Jang AS, Morete A, Bożek A, Nowak-Wegrzyn AH, Ellis AK, Irani C, Panaitescu CB, Rondón C, Zubrinich C, Betancourt Sánchez D, González-Mancebo E, Hidalgo Castro EM, Ng’ang’a E, Zaitoun FH, Rodrigues Fernandes F, Andoh HD, Chantaphakul H, Kaidashev I, Nasr I, Chong-Neto H, Pereira C, Dorsainvil JC, Tracy JM, Li J, Trujillo J, Jamalyan KR, Gáspár K, Ahmetaj L, Worm M, Staevska M, Atanasković-Marković M, Bukovskis M, Valentin Rostan M, Gharnaout M, Gotoh M, Al-Ahmad M, Sonomjamts M, Nagendra Prasad K, Odusote O, Monge Ortega OP, Tsilochristou O, Demoly P, Stepaniuk P, Panzner P, Li PH, Aguilera-Insunza R, Sepiashvili R, Asero R, Ali Tarazona Martinez R, Altrichter S, Husain S, Karabus SJ, Uriarte SA, de Barayazarra S, Huq SR, Abbas SS, Zuberbier T, Sahiner UM, Aun Rufino Pereira V, Patella V, Kvedariene V, Tal Y, Ispayev Z, Martin BL.
   World Allergy Organ J. 2026;19(10):101442. doi: 10.1016/j.waojou.2026.101442.
    
3. The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
   Zuberbier T, Abdul Hameed Ansari Z, Abdul Latiff AH, Abuzakouk MM, Agcaoili-De Jesus MS, Agondi RC, Al-Ahmad M, Alangari AA, Alhameli H, Alonso Bello CD, Alshareef S, Al-Tamemi S, Altrichter S, Al Wahshi H, Aquilina S, Araújo M, Arnaout R, Asero R, Ballmer-Weber B, Bangert C, Bauer A, Ben-Shoshan M, Bernstein JA, Bindslev-Jensen C, Bizjak M, Boccon-Gibod I, Bonnekoh H, Bouillet L, Brockow K, Brzoza Z, Bulatović Ćalasan M, Bulkhi A, Buttgereit T, Bygum A, Caballero T, Calderon O, Campos R, Cancian M, Carne E, Castor MA, Cerecedo I, Çetinarslan T, Cherrez-Ojeda I, Chkhikvadze N, Chong-Neto HJ, Choo K, Christoff G, Chu CY, Ciupka K, Conlon N, Costa C, Craig T, Criado P, Danilycheva I, Darlenski R, De Arruda Chaves E, de Montjoye L, Doutre MS, Du-Thanh A, Ebo D, Elkhalifa S, Elmariah S, El-Shanawany T, Ensina LF, Ertaş R, Fachini Jardim Criado R, Ferrer M, Ferrucci S, Fok JS, Fomina D, Fonacier L, Fouda G, Francescantonio I, Fukunaga A, Galvan Calle CA, Garcia E, Gáspár K, Gelincik A, Geng S, Godse K, Gonçalo M, Gotua M, Grattan C, Grosber M, Guidos Fogelbach G, Guilarte M, Guillod R, Hamelmann E, Hawkes J, Hayama K, Heuer R, Hide M, Hoetzenecker W, Inomata N, Kang HR, Kaplan A, Kapp A, Karam M, Kasperska-Zajac A, Katelaris CH, Kessel A, Khoshkhui M, Kim B, Kinaciyan T, Kocatürk E, Kolacinska-Flont M, Kolkhir P, Konstantinou GN, Kosnik M, Krasowska D, Kulthanan K, Kumaran MS, Kuprys-Lipinska I, Labrador M, Larco JI, Larenas-Linnemann D, Latysheva E, Lazaridou E, Li PH, Lima H, Lippert U, Magerl M, Makris M, Alves Marcelino J, Marzano AV, Medina I, Meshkova R, Micallef D, Mohammed Ali R, Mortz CG, Munoz M, Oude Elberink HNG, Nakonechna A, Nasr I, Nast A, Netchiporouk E, Nettis E, Nieto S, Ogueta Canales I, Okas T-L, Orfali RL, Özkaya E, Parisi C, Pennitz A, Pawankar R, Pereira MP, Peter J, Petkova E, Pigatto PD, Podder I, Popov T, Porebski G, Pyatilova P, Ramon GD, Ratti Sisa HA, Recto M, Ress K, Ridge K, Riedl M, Ritchie C, Rosario Filho N, Rosmaninho I, Rudenko M, Rukhadze M, Rutkowski K, Sabato V, Sahiner UM, Saini S, Saleh Al Sabbagh F, Salman A, Salvo F, Sanchez J, Santucci A, Schliemann S, Schmid-Grendelmeier P, Sekerel BE, Serpa F, Sheikh F, Sheikh J, Shendi H, Siebenhaar F, Sonomjamts M, Soria A, Sousa Pinto B, Staevska M, Staubach P, Stephan M, Stevanovic K, Stingeni L, Stobiecki M, Su Küçük Ö, Sussman G, Szegedi A, Takahagi S, Tanaka A, Teovska Mitrevska N, Thomsen SF, Toubi E, Tsatsou F, Turk M, Vadasz Z, Valerieva A, Valle S, Doorn MV, Veleiro Perez B, Vera Ayala CE, Vestergaard C, Vieira RJ, Maruta CW, Wedi B, Werner RN, Yap EWY, Xepapadaki P, Xiang Y, Ye Y-M, Yong P, Yosipovitch G, Zalewska-Janowska AZJ, Zeyen C, Zhao Z, Metz M, Giménez-Arnau AM.
   Allergy. 2026 Feb 6. doi: 10.1111/all.70210. 
    
4. The 2025 WAO Guidelines for the classification, diagnosis, and treatment of hereditary angioedema, with consideration of worldwide disparities
   Vázquez DO, Giavina-Bianchi P, Josviack D, Kaplan AP, Martinez PAS, Fantini C, Bernstein JA, Abbas S, Agmon Levin N, Al-Ahmad M, Alandijani S, Alhashmi HA, Mohammed Ali R, Allam I, Al-Nesf Al-Mansouri M, Al-Tamemi S, Altrichter S, Álvarez Castelló M, Andoh HD, Vivolo Aun M, Babu Mapondela K, Banerji A, Bara NA, Barrera OM, Barrera Perigault P, Branco-Ferreira M, Calderón-Llosa OM, Canonica GW, Castro Almarales R, Cecchi L, Chang YS, Chantaphakul H, Chikovani T, Chong-Neto HJ, Contreras-Verduzco FA, Defendi F, Dorsainvil V, Ebisawa M, El-Sayed ZA, Fasano MB, Fazlollahi MR, Femine E, Rodrigues Fernandes F, Fiocchi A, Fonacier L, Gallego C, García Abujeta JL, Gereda JE, Giordano E, Gökmen NM, Gómez RM, Gonzalez M, González Díaz S, Grau M, Hakl R, Hide M, Hossny E, Huilaja L, Huq SR, Irani C, Ishchanka A, Ispayeva Z, Jamalyan KR, Kaidashev I, Kamkamidze G, Kase Tanno L, Kathuria PC, Kessel A, Kiani-Alikhan S, Komarla NP, Kvedarienė V, Lang DM, Lee YW, Levin M, Li PH, Li H, Lumry WR, Machavariani K, Martinez-Sager I, Maselli JP, Mikos N, Mitskevich N, Mobayed HMS, Monge Ortega OP, Morita H, Munkhbayarlakh S, Nabavi M, Naqvi MR, Ocampo J, Olivares M, Ortega-Martell JA, Oyuntsatsral B, Papadopoulos N, Patella V, Pawankar R, Peter J, Psarros F, Regateiro F, Reidl M, Rigalt AM, Rincón Fernández JM, Rivera Gómez MA, Rojo Gutiérrez MI, Sahiner UM, Sandoval-Ruballos M, Santos N, Sarrazola M, Schrijvers R, Shchurok I, Sheikh FR, Sobotkova M, Soria A, Stefanaki E, Tarazona R, Valecillos Luján A, Valentin Rostan M, Valerieva A, Wong GWK, Yong PFK, Zaitoun F, Martin BL, Ansotegui IJ, Morais-Almeida M, Craig TJ.
   World Allergy Organ J. 2026 May 19; 19(5):101335. doi: 10.1016/j.waojou.2026.101335.
    
5. Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment
   Zuraw BL, Bork K, Bouillet L, Christiansen SC, Farkas H, Germenis AE, Grumach AS, Kaplan A, López-Lera A, Magerl M, Riedl MA, Adatia A, Banerji A, Betschel S, Boccon-Gibod I, Bova M, Boysen HB, Caballero T, Cancian M, Castaldo AJ, Cohn DM, Corcoran D, Drouet C, Fukunaga A, Hide M, Katelaris CH, Li PH, Longhurst H, Peter J, Psarros F, Reshef A, Ritchie B, Selva CN, Zanichelli A, Maurer M.
   Clin Rev Allergy Immunol. 2025 Mar 7;68(1):24. doi: 10.1007/s12016-025-09027-4.
    
6. APAAACI clinical pathway on direct provocation testing for penicillin allergy delabeling
   Li PH (Corresponding author), Thong BYH, Pawankar R, Jeewandara C, Lobo RCM, Kang HR, Mahesh PA, Meng J, Munkhbayarlakh S, Pham DL, Rerkpattanapipat T, Tang MM, Wang JY, Yamaguchi M, Abdul Latiff AH, Rengganis I, Wang JY, Zhang L, Lucas M.
   Asia Pac Allergy 2023 Dec;13(4):142-147. doi: 10.5415/apallergy.0000000000000122.
    
7. Hong Kong-Macau Severe Hives & Angioedema Referral Pathway
   Li PH (Corresponding author), Au EYL, Cheong SL, Chung L, Fan KI, Ho MHK, Leung AS, Chung MMH, Wong JCY, Coelho R.
   Front Allergy 2023 Dec 6;4:1290021. doi: 10.3389/falgy.2023.1290021.
    
8. Hong Kong Drug Allergy Delabelling Initiative (HK-DADI) Consensus Statements for Penicillin Allergy Testing by Non-Allergists
   Li PH (Corresponding author), Wong JCY, Chan JMC, Chik TSH, Chu MY, Ho GCH, Leung WS, Li TCM, Ng YY, Shum R, Sin WWY, Tso EYK, Wu AKL, Au EYL.
   Front Allergy. 2022 3:974138. doi: 10.3389/falgy.2022.974138.
    
9. Updated Consensus Statements on COVID19 Vaccine Allergy Safety in Hong Kong
   Chiang V, Leung AS, Ho MH, Au E, Lee TH, Wu AY, Wong GWK, Li PH (Corresponding author),
   Asia Pac Allergy 2022 Jan;12(1):e8. doi: 10.5415/apallergy.2022.12.e8.
    
10. Consensus Statements on the Approach to COVID19 Vaccine Allergy Safety in Hong Kong
    Chiang V, Leung AS, Ho MH, Au E, Lee TH, Wu AY, Wong GWK, Li PH (Corresponding author),
    Front Allergy. 2021 Jul 14;2:690837. doi: 10.3389/falgy.2021.690837.
     
11. Hong Kong Anaphylaxis Consortium Consensus Statements on Prescription of Adrenaline Autoinjectors
    Li PH (Corresponding author), Chua GT, Leung ASY, Chan YC, Chan KKL, Cheung KH, Chong PCY, Ho PPK, Kwan MYW, Lai JCH, Lam KK, Lam TSK, Leung TF, Li TY, Rosa Duque JS, So JLT, Wan KA, Wong HCY, Lam EH, Wu AYY, Lee TH, Ho MHK, Siu AYC.
    Asia Pac Allergy. 2021 Jan 6;11(1):e1. doi: 10.5415/apallergy.2021.11.e1.
     
12. Hong Kong Institute of Allergy and Hong Kong Society for Paediatric Immunology Allergy & Infectious Diseases joint consensus statement 2018 on vaccination in egg-allergic patients
    Chua GT, Li PH, Ho MHK, Lai E, Ngai V, Yau FYS, Kwan MYW, Leung TF, Lee TH.
    Hong Kong Med J. 2018 Oct;24(5):527-531. doi: 10.12809/hkmj177137

• U21 Health Sciences Group Teaching Excellence Award (Universitas 21) 2026
• Young Physician Leader (The InterAcademy Partnership) 2026
• Supervisor of Winner of Best Thesis Award (Hong Kong College of Physicians) 2026
• Faculty Knowledge Exchange Award (LKS Faculty of Medicine, HKU) 2026
• Top Cited Article Award (Clinical & Experimental Allergy) 2026
• Top Author Award for Most Citations (The Journal of Allergy and Clinical Immunology In Practice) 2025
• Best Presentation Award (Japanese Society of Allergology) 2025
• Ten Outstanding Young Persons (Junior Chamber International) 2025
• Research Excellence in Allergic Diseases Award (Hong Kong Institute of Allergy) 2025
• Top Author Award for Most Citations (The Journal of Allergy and Clinical Immunology In Practice) 2025
• Best Presentation Award (Japanese Society of Allergology) 2025
• Faculty Teaching Medal (LKS Faculty of Medicine, HKU) 2025
• Hong Kong Humanity Award (Hong Kong Red Cross) 2025
• Early Career Teaching Award (Teaching Excellence Awards, HKU) 2024
• COVID-19 Research Award (Health Bureau, Hong Kong) 2024
• Best Presentation Award (Japanese Society of Allergology) 2024
• Richard Yu Lectureship (Hong Kong College of Physicians) 2024
• Top Author Award for Most Citations (The Journal of Allergy and Clinical Immunology In Practice) 2024
• Distinguished Research Paper Award for Young Investigators (Hong Kong College of Physicians) 2024
• Silver Medal (Silicon Valley International Invention Festival) 2024
• Top Downloaded Article (Clinical & Experimental Allergy) 2024
• Sir Patrick Manson Gold Medal (LKS Faculty of Medicine, HKU) 2024
• Best Abstract in Basic Science & Translational Research (Medical Research Conference, Hong Kong) 2024
• Best Abstract Award (World Allergy Congress) 2023
• Research Team Award (Hong Kong College of Physicians)
• Best Presentation Award in Oral Presentation (Japanese Society of Allergology) 2023
• Top Downloaded Article (Contact Dermatitis) 2023
• Clinical Service Excellence Award (LKS Faculty of Medicine, HKU) 2022
• Chief Executive’s Commendation for Public Service (Government of Hong Kong SAR) 2022
• Best Abstract in Clinical Research (Medical Research Conference, Hong Kong) 2021
• Award for Highest Score in Advanced Internal Medicine (Hong Kong College of Physicians) 2020
• Best Abstract in Clinical Medicine (Oral) (Medical Research Conference, Hong Kong) 2020
• Best Thesis Award (Hong Kong College of Physicians) 2019
• Best Abstract in Clinical Medicine (Oral) (Medical Research Conference, Hong Kong) 2018
• Best Abstract in Clinical Medicine (Poster) (Medical Research Conference, Hong Kong) 2018

A METHOD AND KIT TO DETERMINE TISSUE OR CELL ORIGIN OF CFDNA AND USE THEREOF TO TRACE TISSUE DAMAGE IN DISEASES

• 63/704,370

CELLULAR DISEASE MODEL FOR INBORN ERRORS OF IMMUNITY AND USE THEREOF

• 63/605,400

• Faculty Knowledge Award 2026 (LKS Faculty of Medicine, HKU)
  Project: The Hong Kong Model for Penicillin "Allergy" Delabelling: Global Knowledge Exchange for Antimicrobial Stewardship
  Amount: HK$100,000
   
• General Research Fund (Research Grants Council, Hong Kong)
  Project: Provocation After Nurse-Directed Assessment (PANDA): Prospective, randomized, head-to-head study comparing nurse-led direct provocation testing vs. standard of care for low-risk penicillin allergy – 17111426
  Amount: HK$1,134,133
   
• HKUMed Research Fellowship Scheme for Clinical Academics (LKS Faculty of Medicine, HKU) 2026
  Project: cfDNA-Based Liquid Biopsy for Precision Medicine in Autoimmune Disease: Non-Invasive Diagnosis and Monitoring of Lupus Nephritis 
  Amount: HK$899,726
   
• Li Shu Pui Medical Foundation Research Grant (Li Shu Fan Medical Foundation, Hong Kong) 2025
  Project: Multidisciplinary Desensitization: Reestablishing Effective Anti-Cancer Treatments (MD: REACT)
  Amount: HK$1,453,100
   
• General Research Fund (Research Grants Council, Hong Kong) 2024
  Project: Recapitulating and repairing inborn errors of immunity using a novel personalized stem cell platform – 17111924
  Amount: HK$1,461,315
   
• Young Investigator Research Grant (Hong Kong College of Physicians) 2024
  Project: Provocation After Nurse-Directed Assessment (PANDA): Randomized, head-to-head study comparing nurse-led direct provocation test vs. standard of care for low-risk penicillin allergy in Hong Kong
  Amount: HK$80,000 
   
• Seed Fund for Basic Research (University of Hong Kong) 2024
  Project: Feasibility of a Penicillin Allergy Nurse-led Diagnostic Assessment Service (PANDAS)
  Amount: HK$46,520 
   
• HKIA Research Grant (Hong Kong Institute of Allergy) 2024
  Project: Feasibility of a Penicillin Allergy Nurse-led Diagnostic Assessment Service
  Amount: HK$60,000 
   
• Croucher Summer Course (Croucher Foundation) 2023
  Project: Translational Immunology
  Amount: HK$1,800,000 
   
• Hong Kong Society of Rheumatology Project Fund (Hong Kong Society of Rheumatology) 2022
  Project: PULSE – Personalizing and Understanding Lupus with Subphenotype Exploration
  Amount: HK$200,000 
   
• Health and Medical Research Fund (Food and Health Bureau) 2021
  Project: HKU Optimizing Protection and Effectiveness (HOPE) of COVID19 Vaccines – COVID1903011
  Amount: HK$12,511,372 
   
• Knowledge Exchange Fund (Knowledge Exchange, HKU) 2020
  Project: A Book to Empower Allergy Patients in Hong Kong – “Living with Allergies”
  Amount: HK$150,000 
   
• Love Can Help Fund (LKS Foundation) 2020
  Project: A study of feasibility and cost-effectiveness of subcutaneous immunoglobulin replacement for antibody deficiency patients in Hong Kong
  Amount: HK$700,000 
   
• Enhanced New Staff Start-up Research Grant (LKS Faculty of Medicine, HKU) 2020
  Project: Impact of delabelling false penicillin allergy in Hong Kong
  Amount: HK$380,000 
   
• Seed Fund for Basic Research (University of Hong Kong) 2020
  Project: Delabelling false penicillin allergy in Hong Kong
  Amount: HK$150,000 
   
• Young Investigator Research Grant (Hong Kong College of Physicians) 2019
  Project: Impact of penicillin allergy testing in Hong Kong
  Amount: HK$50,000 

• Chair of the International Societies Council of the European Academy of Allergy and Clinical Immunology (since 2026)
• President of the Hong Kong Institute of Allergy (since 2024)
• Assistant Chair of Department of HKU-Shenzhen Hospital (since 2024)
• Board Member of the Specialty Board in Rheumatology/Immunology & Allergy (Hong Kong College of Physicians) (since 2024)
• Member of the Sri Lanka Expert Committee to Investigate Recent Incidence of Drug Allergies and their After Effects (since 2023)
• Chairperson of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology Drug Allergy Committee (since 2023)
• Board of Directors, Asia Pacific Association of Allergy, Asthma and Clinical Immunology (since 2022)
• Member of the Department of Health Expert Committee on Clinical Events Following COVID-19 Immunization (since 2021)
• Regional Medical Advisor of Hereditary Angioedema International (HAEi) (since 2020)
• Convener of Hong Kong Society of Rheumatology Immunology Special Interest Group (since 2020)
• Executive Committee Member and Advisor of Hong Kong Allergy Association (since 2019)